This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (5) Citing Articles via Google Scholar Google Scholar Articles by Francis, J. Articles by Antzelevitch, C. Search for Related Content PubMed Articles by Francis, J. Articles by Antzelevitch, C.

STATE-OF-THE-ART PAPER

Atrial Fibrillation and Brugada Syndrome

Johnson Francis, MD, DM, FCSI, FACC^_*,_* and Charles Antzelevitch, PhD, FACC, FAHA, FHRS

^_* Department of Cardiology, Calicut Medical College, Calicut, Kerala, India
Masonic Medical Research Laboratory, Utica, New York.

Manuscript received July 3, 2007; revised manuscript received October 19, 2007, accepted October 29, 2007.

^_* Reprints requests and correspondence: Dr. Johnson Francis, Professor of Cardiology, Calicut Medical College, Calicut, Kerala, India. (Email: francisj{at}cmc.edu.in).

Brugada syndrome is characterized by right bundle branch block pattern with ST-segment elevation in leads V₁ to V₃ and a propensity for sudden cardiac death due to ventricular arrhythmias. The arrhythmogenic substrate in Brugada syndrome may not be restricted to the ventricles, and atrial arrhythmias are being increasingly reported. Incidences of spontaneous atrial arrhythmias vary from 6% to 38% and those of inducible atrial arrhythmias from 3% to 100%. Atrial fibrillation (AF) is the most common atrial arrhythmia found in Brugada syndrome. Enhanced duration of atrial action potential and increased intra-atrial conduction time may contribute to the genesis of atrial arrhythmias in Brugada syndrome. Atrial arrhythmias are an important cause of inappropriate discharge of implantable defibrillators in patients with Brugada syndrome. Hence, implantation of dual-chamber defibrillators and careful programming of single-chamber devices have been recommended. Atrial fibrillation has been associated with mutations in both the sodium and calcium channels of the heart, as well as with cases of Brugada syndrome that could not genotyped to any of the known genes associated with the disease. This observation suggests that the substrate responsible for the development of ventricular arrhythmias also may contribute to arrhythmogenesis in the atria of the heart. The presence of a prominent transient outward current in atria and the observation that episodes of AF are triggered by closely coupled atrial extrasystoles point to the possibility that a substrate similar to that responsible for ventricular arrhythmogenesis underlies the development of AF in patients with Brugada syndrome.

Abbreviations and Acronyms   AF = atrial fibrillation   ECG = electrocardiogram   HV = His ventricular   ICD = implantable cardioverter-defibrillator   INa = sodium channel current

This article has been cited by other articles:

				C. Pappone, A. Radinovic, F. Manguso, G. Vicedomini, S. Sala, F. M. Sacco, G. Ciconte, M. Saviano, M. Ferrari, E. Sommariva, et al. New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: prevalence and clinical significance Eur. Heart J., August 20, 2009; (2009) ehp326v1. [Abstract] [Full Text] [PDF]

				S. W Dubrey, S. K Kohli, P. A Mehta, and R. Grocott-Mason An unusual case of palpitations BMJ, February 11, 2009; 338(feb11_2): a3087 - a3087. [Full Text]